Results 111 to 120 of about 10,524,393 (255)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

FLOSS tools in computer forensics tertiary education

open access: yes, 2008
In this paper we discuss the application of Free, Libre, and Open Source Software (FLOSS) tools in computer forensics education at tertiary level. We argue that FLOSS tools are more suitable than commercial tools, as they provide the opportunity for ...
Bem, Derek   +2 more
core  

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Target Optimisation Studies for the European Spallation Source [PDF]

open access: yes, 2010
The European Spallation Source (ESS) is one of Europe’s biggest and most prestigious science projects. ESS will be the world’s most powerful next generation neutron spallation source for research with neutrons, providing a unique tool for studies of ...
Bungau, Adriana   +2 more
core   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Preparation and Characterization of HIR Multi-Layer Abrasion-Resistant Coating for Hydraulic Concrete

open access: yesBuildings
Hydraulic concrete suffers severe damage from high-velocity sand-bearing water flow. Traditional single-layer coating materials struggle to simultaneously satisfy the requirements of strong adhesion, high abrasion resistance, and long-term durability. In
Yu Chen   +5 more
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Super! Knowledge Journal

open access: yes
"Let me share some of my knowledge with you. Please, I insist. From where this knoledge came, I cannot say for certain. All I can say is for certain. All I can say is that is is in my noggin'.
Source, Christine
core   +1 more source

Home - About - Disclaimer - Privacy